Fig. 6

High FGF9 expression in lymph node metastatic sites CAFs was associated with poor prognosis in patients with GC. a–c The Kaplan–Meier survival analysis revealed that the FGF9 level in primary tumor CAFs, primary tumor cells, and lymph node metastatic sites tumor cells was not associated with prognosis. d High FGF9 expression in lymph node metastatic site CAFs was significantly associated with poor prognosis in patients with GC